Abstract:Purpose: This study aimed to explore the value of miR-181a-2-3p in cisplatin (DDP) treatment effectiveness prediction, and to reveal the function underlying the reversal of DDP resistance in patients with gastric cancer (GC). Methods: miRNA expression dataset of three DDP-resistant GC cell lines and their DDPsensitive parental cell lines obtained from GEO DataSets and GenBank, and functional miRNAs were annotated by bioinformatics analyses. Serum specimens and tumor samples were collected from 91 GC patients for understanding of the interrelation between chemotherapy response and miRNA expression. RT-qPCR validated these miRNAs at the transcriptional level in both gastric cancer cells and 91 gastric cancer patients. The correlation between the miRNAs expression and clinical parameters of the patients were analyzed. Receiver operating characteristics (ROC) analysis has been utilized to assess the diagnostic performance. The MTT and colony formation assays were performed to assess cell proliferation. Flow cytometry was conducted to detect cell apoptosis. DDP-resistant GC cells and their DDP-sensitive parental cells were transfected with miRNA mimic or inhibitor vector to overexpress or downregulate miRNA expression. Results: miR-181a-2-3p as a unique miRNA was found in the common differentially expressed-miRNAs (DE-miRNAs) after miRNA screening and validation from three DDPresistant and DDP-sensitive gastric cancer cell lines. Clinical data analysis displayed that miR-181a-2-3p expression was apparently increased in larger tumor size (>= 5 cm), higher T stage (T4), and chemotherapy resistance. miR-181a-2-3p (AUC=0.926, SE=0.028, 95% CI: 0.872-0.980, p< 0.0001) differentiated chemosensitive GC patients from chemoresistant GC patients. miR-181a-2-3p presented a higher level in gastric cancer, and could serve as a valid biomarker to predict the overall survival of GC patients. Upregulation of miR-181a-2-3p rendered the apoptosis-inducing and anti-proliferative effects of DDP, while downregulating it decreased these effects. Conclusion: miR-181a-2-3p can function as a therapeutic target and a tumor biomarker. Targeting oncogenic miR-181a-2-3p inhibits growth and suppresses cisplatin resistance of gastric cancer.

Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p

Identification of miRNA-338-5P as an effector of the tumor suppressor activity of immunized anticancer bioactive peptide-3 (TUM2P.1036)

Anticancer Bioactive Peptide‐3 Inhibits Human Gastric Cancer Growth by Suppressing Gastric Cancer Stem Cells

Mir-338-3p Functions As a Tumor Suppressor in Gastric Cancer by Targeting PTP1B

Mir-301a-5p/Scin Promotes Gastric Cancer Progression Via Regulating Stat3 And Nf-Kappa B Signaling

MiR-301a-5p/SCIN promotes gastric cancer progression via regulating STAT3 and NF-κB signaling

MiR-455-3p Inhibits Gastric Cancer Progression by Repressing Wnt/β-catenin Signaling Through Binding to ARMC8.

Mir-1273H-5p Suppresses the Penetration and Pervasion of Gastric Cancer Cells Via Suppressing CXCL12 Expression

Targeting Oncogenic Mir-181A-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer.

Mir-615-3p Promotes Proliferation and Migration and Inhibits Apoptosis Through Its Potential Target CELF2 in Gastric Cancer.

MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2

Decreased KLF3 Expression Via Mir-660-5p Targeting Suppresses Gastric Cancer Cell Progression.

MiRNA-766-3p inhibits gastric cancer via targeting COL1A1 and regulating PI3K/AKT signaling pathway

Mir-96-5p Enhances Cell Proliferation and Invasion Via Targeted Regulation of ZDHHC5 in Gastric Cancer

MiRNA-219a-1-3p inhibits the malignant progression of gastric cancer and is regulated by DNA methylation

Inhibited HDAC3 promotes microRNA-376c-3p to suppress malignant phenotypes of gastric cancer cells by reducing WNT2b

MicroRNA Library-Based Functional Screening Identified Mir-137 As a Suppresser of Gastric Cancer Cell Proliferation

MIR-1265 Regulates Cellular Proliferation and Apoptosis by Targeting Calcium Binding Protein 39 in Gastric Cancer And, Thereby, Impairing Oncogenic Autophagy.

Mir‐133a‐3p/foxp3 Axis Regulates Cell Proliferation and Autophagy in Gastric Cancer

MBD1/HDAC3-miR-5701-FGFR2 Axis Promotes the Development of Gastric Cancer.

MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.